Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 35 - Antineoplastic agents
Patents for A61P 35 - Antineoplastic agents (221,099)
10/1998
10/14/1998CN1196059A Therapeutic compounds
10/14/1998CN1196055A 2-[[2-(2-hydroxyethyl) amino] ethyl]-5-[[2-methylamino) ethyl] amino] [4,3-gh] isoquinolin-6(2H)-one as antitumor agent
10/14/1998CN1196049A Acylated derivatives of melatonin and its analogues, useful as medicaments
10/14/1998CN1195987A Use of carbostyril derivative for inhibiting carcinogenesis
10/14/1998CN1195985A Benzimidazole compounds
10/14/1998CN1195982A Fgfr 3 as marker for mesenchymal skelftal progenitor cells
10/14/1998CN1195522A Use of 2(3) tertiary butyl-4-hydroxy-anisole in preparation of drug for preventing and curing tissue organ traumatic disease
10/14/1998CN1040212C Chlorophyll and bacteriochlorophyll derivatives, their preparation and pharmaceutical compositions
10/14/1998CN1040211C Matrix metalloprotease inhibitors
10/13/1998US5821366 1,3-disubsituted-zanthines to treat diseases associated with proteins that mediate cellular activity
10/13/1998US5821365 Compounds as enzyme inhibitors for kinases formed by reaction of amine with anhydride group to form indolmaleimide macrocycles
10/13/1998US5821363 Antineoplastic use and pharmaceutical compositions containing them
10/13/1998US5821354 Synthesizing a dna sequence in at least two parts; labeling the 5' end of one with a radioisotope; hybridizing; ligating; useful to prevent uncontrolled cellular proliferation
10/13/1998US5821337 Immunoglobulin variants
10/13/1998US5821264 Used in foodstuffs and dietary supplements to decrease lipoprotein concentration or increase feed conversion
10/13/1998US5821262 Hydroxamic acid derivatives as inhibitors of cytokine production
10/13/1998US5821246 Aniline derivatives
10/13/1998US5821245 Use of naphthalene derivatives in treating lung carcinoma
10/13/1998US5821240 Pyrimido 5,4!-dipyrimidines, pharmaceuticals containing them, their use and processes for the preparation thereof
10/13/1998US5821238 Administering to patient to impair tumor growth
10/13/1998US5821236 Tumor treatment with arabinofuranosyl purine derivatives
10/13/1998US5821230 GnRH antagonist decapeptides
10/13/1998US5821227 Modulators of cytokines of the tgf β superfamily
10/13/1998US5821221 Drug delivery; sustained release
10/13/1998US5821122 Isolated nucleic acid molecules, peptides which form complexes with MHC molecule HLA-A2 and uses thereof
10/13/1998US5821070 Antibodies reactive with retinoblastoma binding proteins and methods of using same
10/13/1998US5821056 Polynucleotide; expression vector; binding of antibody to a growth differentiation factor-9 polypeptide indicates the presence of an oocyte
10/13/1998US5821051 Combining e6 protein, e6 binding protein, and test compound,detecting formation of complex; identifying agents which affect protein binding; human papillomavirus
10/13/1998US5820872 Methods and compositions for improving the effectiveness of X-irradiation therapy for the treatment of an internal solid tumor
10/13/1998US5820859 Administering a drug congugated to an antibody specific for the extracellular domain of gp180(erbb-3), which will not bind to erbb-2 or erbb; human mammary tumor line targeting
10/13/1998CA2132578C Method of tumor treatment
10/08/1998WO1998044143A1 Polymer-modified viruses
10/08/1998WO1998044133A1 Reagents and methods useful for detecting diseases of the gastrointestinal tract
10/08/1998WO1998044101A1 Antisense oligonucleotides for mitogen-activated protein kinases as therapy for breast cancer
10/08/1998WO1998044096A2 Mycobacterium recombinant vaccines
10/08/1998WO1998043996A1 Active substance and composition inhibiting tumorous proliferation in ectoderm derived tissues
10/08/1998WO1998043974A1 Pyrimidopyrimidine compounds
10/08/1998WO1998043963A1 Metalloproteinase inhibitors, pharmaceutical compositions containing them and their pharmaceutical uses
10/08/1998WO1998043960A1 Substituted 3-cyano quinolines
10/08/1998WO1998043678A2 Tetraaza- or n2s2- complexants, and their use in radiodiagnostics or radiotherapy
10/08/1998WO1998043645A1 Inhibitors for the formation of glycosylated protein denaturation products
10/08/1998WO1998043641A1 Pharmaceutical, cosmetic and/or food composition with antioxidant properties
10/08/1998WO1998043482A1 Fibrocyte-based cellular therapy formulations
10/08/1998WO1998030558A3 Tricyclic compounds useful for inhibition of farnesyl protein transferase
10/08/1998CA2293359A1 Pharmaceutical, cosmetic and/or food composition with antioxidant properties
10/08/1998CA2285416A1 Polymer-modified viruses
10/08/1998CA2285372A1 Metalloproteinase inhibitors, pharmaceutical compositions containing them and their pharmaceutical uses
10/08/1998CA2285241A1 Substituted 3-cyano quinolines
10/08/1998CA2285039A1 Reagents and methods useful for detecting diseases of the gastrointestinal tract
10/08/1998CA2284811A1 Pyrimidopyrimidine compounds
10/08/1998CA2284736A1 Mycobacterium recombinant vaccines
10/08/1998CA2284471A1 Fibrocyte-based cellular therapy formulations
10/08/1998CA2281903A1 Antisense oligonucleotides for mitogen-activated protein kinases as therapy for breast cancer
10/07/1998EP0869180A1 A TNF homologue, TL5
10/07/1998EP0869179A1 Tumor necrosis related receptor, TR7
10/07/1998EP0869178A1 SAF-3, Sialoadhesin family member-3
10/07/1998EP0869116A1 Ortho-substituted benzoylguanidines, process for their preparation, their use as medicament or diagnostic agent as well as medicaments containing them
10/07/1998EP0868920A2 Hybrid protein for treatment of bladder cancer cells
10/07/1998EP0868532A1 METHODS FOR DETERMINING COMPOUNDS CAPABLE OF INHIBITING THE ACTIVITIES OF THE Ha-ras ONCOGENE
10/07/1998EP0868519A1 Diagnosis and treatment of aur-1 and/or aur-2 related disorders
10/07/1998EP0868512A2 Nucleotide sequences, proteins, drugs and diagnostic agents for treating cancer
10/07/1998EP0868434A1 Anti-idiotypic antibodies of vascular endothelial growth factor and use thereof as drugs
10/07/1998EP0868430A1 Therapeutic compositions
10/07/1998EP0868425A1 Phospholipid derivatives of phosphono-carboxylic acids, the production of said derivatives and the use of said derivatives as antiviral medicaments
10/07/1998EP0868198A1 FC$g(e)-PE CHIMERIC PROTEIN FOR TARGETED TREATMENT OF ALLERGY RESPONSES, A METHOD FOR ITS PRODUCTION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME
10/07/1998EP0868195A2 Control of protein synthesis, and screening method for agents
10/07/1998EP0868194A1 Combination of g-csf with a chemotherapeutic agent for stem cell mobilisation
10/07/1998EP0868189A1 Antineoplastic methods and compositions employing (+)-fotemustine
10/07/1998EP0868178A1 Antagonists of gonadotropin releasing hormone
10/07/1998EP0868174A1 Oral gel capsule formulation of 1,2,4-benzotriazine oxides
10/07/1998EP0701440A4 Tri(platinum) complexes
10/07/1998CN1195375A Angiostatin fragments and aggregate angiostatin and methods of use
10/07/1998CN1195340A Inhibitors of farnesyl-protein transferase
10/07/1998CN1195295A Method and use of connective tissue growth factor as revellent
10/07/1998CN1195288A Use of fluconazole for inhibiting growth of cancers
10/07/1998CN1194976A Ortho-substituted benzoylguanidines, process for their preparation, their use as medicament, and medicament comprising them
10/07/1998CN1194830A Partial low-released peroxide dismutase inhibitor
10/07/1998CN1194829A Partial slow-released glutathione inhibitor
10/06/1998US5817800 Inhibitors of β-glucuronidase and their use in the treatment of carcinamatosis and inflammation
10/06/1998US5817796 C-myb ribozymes having 2'-5'-linked adenylate residues
10/06/1998US5817790 Reshaped human antibody to human interleukin-6 receptor
10/06/1998US5817771 Cell-targeted lytic pore-forming agents
10/06/1998US5817753 Antigenic modification of polypeptides
10/06/1998US5817742 Polymer-conjugated malonic acid derivatives and their use as medicaments and diagnostic agents
10/06/1998US5817677 5-membered heterocycles, medicaments containing these compounds, their use and processes for their preparation
10/06/1998US5817669 Compounds, processes for the preparation thereof and anti-tumor agents
10/06/1998US5817664 Uracil reductase inactivators
10/06/1998US5817659 Stable crystalline tetrahydrofolic acid salts
10/06/1998US5817649 Administering reductase inhibitor and an androgen receptor antagonist
10/06/1998US5817648 Vitamin D3 analogues having an unsaturated side chain
10/06/1998US5817636 Genetic construct, radiation-responsive enhancer-promoter region
10/06/1998US5817513 Immunotherapy for cancer
10/06/1998US5817497 Glutathione s-transferase
10/06/1998US5817494 Anticancer agents; viricides
10/06/1998US5817485 Nucleic acids and cells for recombinant production of fibroblast growth factor-10
10/06/1998US5817321 Biological agent compositions
10/06/1998US5817313 Monoclonal antibodies and conjugates thereof useful for the treatment of cancer
10/06/1998CA2082824C Pseudomonas exotoxin multifunctional fusion proteins having carboxyl alterations with increased cytotoxicity
10/02/1998CA2233787A1 Sialoadhesin family member-3
10/02/1998CA2233785A1 Tumor necrosis related receptor, tr7
1 ... 1994 1995 1996 1997 1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 ... 2211